FT 10718: Biotechnology Portfolio, Series 61 - Cash logo

FT 10718: Biotechnology Portfolio, Series 61 - Cash (FRGBDX)

Market Closed
NASDAQ NASDAQ
- Market Cap
- Div Yield
- Volume
Want to track FRGBDX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

FRGBDX is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

FT 10718: Biotechnology Portfolio, Series 61 - Cash (FRGBDX) FAQ

On which exchange is it traded?

FT 10718: Biotechnology Portfolio, Series 61 - Cash is listed on NASDAQ.

What is its stock symbol?

The ticker symbol is FRGBDX.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has FT 10718: Biotechnology Portfolio, Series 61 - Cash ever had a stock split?

No, there has never been a stock split.